首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Cancer

Journal Of Cancer杂志,由Ivyspring International Publisher出版,于2010年创刊,12 issues/year,出版语言English,ISSN:1837-9664,E-ISSN:1837-9664。

投稿咨询
Journal Of Cancer
Journal Of Cancer
Journal Of Cancer
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.4
CiteScore
5.6
期刊收录
SCI、SCIE

Journal Of Cancer(中文译名:《癌症杂志》),ISSN:1837-9664,EISSN:1837-9664,是Ivyspring International Publisher出版的国际性学术期刊,创刊于2010年,以12 issues/year形式稳定发行,2026年总发文量约329篇。该刊采用OA开放访问,学科归属为ONCOLOGY。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.4,2025年期刊CiteScore为5.6,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Cancer长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期12 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、South Korea、Japan、Taiwan、GERMANY (FED REP GER)、Greece等为核心发文国家与地区;SUN YAT SEN UNIVERSITYFUDAN UNIVERSITY、STATE KEY LAB ONCOLOGY SOUTH CHINA、CENTRAL SOUTH UNIVERSITY、SHANGHAI JIAO TONG UNIVERSITY、NANJING MEDICAL UNIVERSITY、ZHEJIANG UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区
否 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区
否 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区
否 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 148 / 333

55.7

学科:ONCOLOGY SCIE Q2 133 / 333

60.21

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 118 / 322

63.5

学科:ONCOLOGY SCIE Q2 121 / 322

62.58


中国学者近期发文

1
High PMS2 Expression-Based Nomogram for Risk Stratification in Resected Hepatocellular Carcinoma: Application to Recurrence and Neoadjuvant Therapy Selectio

Author:Gong, Wenchen; Han, Ruyu; Sun, Liyu; Gao, Yingrui; Han, Zhiqiang; Wang, Yimeng; Xia, Yuren; Wei, Yukun; Song, Tianqiang; Chen, Lu; Tian, Xiangdong

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 4, pp. 771-786. DOI: 10.7150/jca.131997

2
WISP-3 promotes angiogenesis in non-small cell lung cancer through p38/JNK-c-Jun-mediated PDGF-A upregulatio

Author:Chang, En-Ming; Lin, Syuan-Ling; Cheng, Ching-Yuan; Tang, Chih-Hsin; Chen, Yu-Chen; Lee, Chiang-Wen; Lin, Chih-Yang

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 4, pp. 787-796. DOI: 10.7150/jca.127681

3
Roles of Cellular Neighborhoods in Lung Cance

Author:Bai, Rui; Sun, Wenjie

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 4, pp. 759-770. DOI: 10.7150/jca.132848

4
Longitudinal CT-based deep learning radiomics for predicting prognosis in esophageal squamous cell carcinoma treated with definitive chemoradiotherapy: a two-center stud

Author:Hu, Xinyang; Maitudi, Wubulaishan; Chen, Xi; Zhao, Lina; Pang, Qingsong

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 4, pp. 808-818. DOI: 10.7150/jca.126804

5
Therapeutic Targeting of Oxidative Phosphorylation in Microsatellite Instability-High Gastric Cance

Author:Ang, Bing; Bai, Yi; Deng, Xiyue; Wu, Qiong; Wang, Yuqian; Xu, Shanshan; Zhang, Weixin; Li, Yang; Chen, Dapeng; Li, Ruixi; Li, Siyang; Zhao, Zhigang; Zhang, Yamin

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 4, pp. 797-807. DOI: 10.7150/jca.127225

6
Molecular Mechanisms of Symptom Fluctuations in Malignant Tumor Patients: Stable by Day and Severe at Nigh

Author:Xie, Zhongxuan; Jin, Wei; Pang, Juezhou; Hu, Kangshuo; Li, Lihong

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 3, pp. 571-582. DOI: 10.7150/jca.128423

7
Potential influence of omentin-1 genetic variants on the clinicopathological features of patients with hepatocellular carcinom

Author:Hu, Sung-Lin; Lee, Hsiang-Lin; Lien, Ming-Yu; Wu, Edie-Rosmin; Yang, Shun-Fa; Tang, Chih-Hsin

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 3, pp. 564-570. DOI: 10.7150/jca.128357

8
FAM188B promotes progression of hepatocellular carcinoma by regulating YAP/TAZ via interaction with USP1

Author:Hu, Siwei; Wen, Yuting; Chen, Yihong; Fang, Yuliang; Mu, Mingshan; Tu, Linglan; Chen, Wenhu; Tu, Kangsheng; Liu, Xin; Xu, Qiuran; Huang, Dongsheng; Li, Xiaoyan

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 3, pp. 626-636. DOI: 10.7150/jca.125659

9
Fluid-Derived Organoids from Pleural Effusion and Ascites: Emerging Models for Drug Resistance and Personalized Oncolog

Author:Chen, Yongyang; Xu, Xiaoqing; Chen, Jialin; Yin, Miao; Chen, Jinhui; Qi, Zhanghua; Shi, Ming; Su, Wenmei

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 3, pp. 614-625. DOI: 10.7150/jca.127511

10
Integrative analysis of lysosome-dependent cell death related molecular subtypes and prognosis prediction in papillary thyroid carcinom

Author:Xu, Ying; Wang, Qiong; Zhang, Na; He, Fugeng; Mao, Xiaochun

Journal: JOURNAL OF CANCER. 2026; Vol. 17, Issue 3, pp. 646-661. DOI: 10.7150/jca.129191


在线咨询

Journal Of Cancer

国际简称:J CANCER参考译名:癌症杂志

年发文量:329 CiteScore:5.6 是否预警:否 Gold OA文章占比:99.20% 研究类文章占比:89.97%

杂志社联系方式:PO BOX 4546, LAKE HAVEN, AUSTRALIA, NSW, 2263

Journal Of Cancer